5-Fu Plus Epirubicin is Superior to Standard 5-FU Plus Cisplatin and Epirubicin in the Neoadjuvant Gastric Cancer Spheroid Model

combination of 5-fu and epirubicin in the treatment of advanced gastric cancer

this study was undertaken to assess the effectiveness of 5-fu plus epirubicin in the treatment of the advanced gastric cancer. for this purpose, 22 patients with no previous treatment were studied. all of the patients were unoperable or metastatic. follow up checking continued for 24 months. our selected therapeutic regimen consisted of a combination of 500 mg/m2 5-fu dialy for five days, and 7...

Pharmacokinetics of cisplatin and combination chemotherapy of cisplatin plus 5-FU.

UFT plus calcium folinate vs 5-FU plus calcium folinate in colon cancer.

Adjuvant chemotherapy has been shown to alter the natural history of resected colon cancer. Two regimens (5-fluorouracil [5-FU] plus calcium folinate and 5-FU plus levamisole [Ergamisol]) have been found to prolong disease-free survival and overall survival in affected patients. Previous comparisons of these two regimens indicate that 5-FU plus calcium folinate may offer a small disease-free su...

The Efficacy and Toxicity of Paclitaxel Plus S-1 Compared With Paclitaxel Plus 5-Fu for Advanced Gastric Cancer

The standard treatment for patients with advanced gastric cancer (AGC) is still a matter of debate. The chemotherapy regimen of paclitaxel (PTX) combined with S-1 has been used to treat AGC or metastatic gastric cancer.We conducted a meta-analysis to compare oral S-1 and infusional 5-fluorouracil (5-FU) to determine which agent was more efficacious and less toxic in combination with PTX. A syst...

Neoadjuvant Dose-Dense Gemcitabine plus Docetaxel and Vinorelbine plus Epirubicin for Operable Breast Cancer

BACKGROUND Neoadjuvant anti-tumor activity of an alternating taxane- and anthracycline-based dose-dense regimen in patients with operable, non-inflammatory large breast cancer was investigated. OBJECTIVE The objective is to study the rate of pathological complete response in patients with breast cancer receiving dose-dense chemotherapy sequentially with gemcitabine plus docetaxel and vinorelb...